UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.342

Sortiert nach

Anti‐infective properties of epigallocatechin‐3‐gallate (EGCG), a component of green tea

British journal of pharmacology, 2013-03, Vol.168 (5), p.1059-1073

2013

Link zum Volltext

Verfügbarkeit prüfen

Virucidal activity of oral, hand, and surface disinfectants against respiratory syncytial virus

The Journal of hospital infection, 2023-11, Vol.141, p.25-32

2023

Link zum Volltext

Verfügbarkeit prüfen

Characterization of Cell Lines Carrying Self-Replicating Hepatitis C Virus RNAs

Journal of Virology, 2001-02, Vol.75 (3), p.1252-1264

2001

Link zum Volltext

Verfügbarkeit prüfen

CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells

Journal of general virology, 2009-01, Vol.90 (1), p.48-58

2009

Link zum Volltext

Verfügbarkeit prüfen

Transcriptome analysis reveals a classical interferon signature induced by IFNλ4 in human primary cells

Genes and immunity, 2015-09, Vol.16 (6), p.414-421

2015

Link zum Volltext

Verfügbarkeit prüfen

Transcriptome analysis reveals a classical interferon signature induced by IFN lambda 4 in human primary cells

Genes and immunity, 2015-09, Vol.16 (6), p.414-421

2015

Link zum Volltext

Verfügbarkeit prüfen

Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway

Journal of general virology, 2001-04, Vol.82 (Pt 4), p.723-733

2001

Link zum Volltext

Verfügbarkeit prüfen

838 TWO METHODS TO IDENTIFY CLINICAL HCV ISOLATES FOR IN VITRO STUDIES

Journal of hepatology, 2012-04, Vol.56, p.S327-S327

2012

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C virus enters human peripheral neuroblastoma cells - evidence for extra-hepatic cells sustaining hepatitis C virus penetration

Journal of viral hepatitis, 2011-08, Vol.18 (8), p.562-570

2011

Link zum Volltext

Verfügbarkeit prüfen

Long‐term follow‐up of successful hepatitis C virus therapy: waning immune responses and disappearance of liver disease are consistent with cure

Alimentary pharmacology & therapeutics, 2015-03, Vol.41 (6), p.532-543

2015

Link zum Volltext

Verfügbarkeit prüfen

Thermostability of seven hepatitis C virus genotypes in vitro and in vivo

Journal of viral hepatitis, 2013-07, Vol.20 (7), p.478-485

2013

Link zum Volltext

Verfügbarkeit prüfen

1189 NEXT GENERATION SEQUENCING AND IN VITRO CHARACTERIZATION REVEAL POPULATION BOTTLENECKS AND FIXATION OF SELECTIVELY NEUTRAL MUTATIONS OCCURS POST-BI 201335 THERAPY

Journal of hepatology, 2013-04, Vol.58, p.S483-S484

2013

Link zum Volltext

Verfügbarkeit prüfen

P233 THE NATURAL COMPOUND PENTA-O-GALLOYL-GLUCOSE, DERIVED FROM THE ROOT CORTEX MOUTAN, EFFICIENTLY INHIBITS HEPATITIS C-VIRUS ENTRY AND SHOWS EXCELLENT PHARMACOKINETIC PERFORMANCE IN VIVO

Journal of hepatology, 2014-04, Vol.60 (1), p.S143-S143

2014

Link zum Volltext

Verfügbarkeit prüfen

64 IDENTIFICATION AND CHARACTERIZATION OF A HEPATITIS C VIRUS CAPSID ASSEMBLY INHIBITOR

Journal of hepatology, 2011-03, Vol.54, p.S29-S29

2011

Link zum Volltext

Verfügbarkeit prüfen

770 REGULATION OF HEPATITIS C VIRUS REPLICATION, VIRUS PRODUCTION AND INFECTIVITY BY BILE ACIDS

Journal of hepatology, 2011-03, Vol.54, p.S310-S310

2011

Link zum Volltext

Verfügbarkeit prüfen

G09 : Targeting a host-cell entry factor barricades antiviral resistant HCV variants from on-therapy breakthrough in human-liver mice

Journal of hepatology, 2015-04, Vol.62, p.S214-S214

2015

Link zum Volltext

Verfügbarkeit prüfen

The larger attachment glycoprotein of respiratory syncytial virus produced in primary human bronchial epithelial cultures reduces infectivity for cell lines

PLoS pathogens, 2021-04, Vol.17 (4), p.e1009469-e1009469

2021

Link zum Volltext

Verfügbarkeit prüfen

866 INACTIVATION OF HEPATITIS C VIRUS BY HUMAN MOTHER'S MILK

Journal of hepatology, 2012-04, Vol.56, p.S337-S338

2012

Link zum Volltext

Verfügbarkeit prüfen

P763 ANALYSIS OF HCV MARKERS AND IMMUNE RESPONSES 5–20 YEARS AFTER SUCCESSFUL HCV THERAPY SUGGESTS THAT MOST PATIENTS ARE CURED

Journal of hepatology, 2014-04, Vol.60 (1), p.S325-S325

2014

Link zum Volltext

Verfügbarkeit prüfen

1238 CULTURE LONG-TERM TREATMENT WITH IMINOSUGARS-BASED HCV ASSEMBLY INHIBITORS DOES NOT LEAD TO VIRAL BREAKTHROUGH IN TISSUE CULTURE

Journal of hepatology, 2011-03, Vol.54, p.S489-S489

2011

Link zum Volltext

Verfügbarkeit prüfen

P0674 : Clinically approved T-type calcium channel inhibitors prevent hepatitis C virus (HCV) membrane fusion in a genotype-dependent manner

Journal of hepatology, 2015-04, Vol.62, p.S574-S575

2015

Link zum Volltext

Verfügbarkeit prüfen

877 OXIDIZED LOW DENSITY LIPOPROTEIN (OXLDL) IS A PAN-GENOTYPE INHIBITOR OF HCV ENTRY THAT ACTS IN A SR-BI DEPENDENT MANNER

Journal of hepatology, 2012-04, Vol.56, p.S341-S342

2012

Link zum Volltext

Verfügbarkeit prüfen

872 IMPACT OF ANTI-RETROVIRAL AGENTS ON SUSCEPTIBILITY TO AND REPLICATION OF HEPATITIS C VIRUS IN VITRO

Journal of hepatology, 2012-04, Vol.56, p.S340-S340

2012

Link zum Volltext

Verfügbarkeit prüfen

1162 TURMERIC CURCUMIN INHIBITS ENTRY OF ALL HEPATITIS C VIRUS GENOTYPES INTO HUMAN LIVER CELLS

Journal of hepatology, 2013-04, Vol.58, p.S473-S473

2013

Link zum Volltext

Verfügbarkeit prüfen

A Particle-Associated Glycoprotein Signal Peptide Essential for Virus Maturation and Infectivity

Journal of Virology, 2001-07, Vol.75 (13), p.5762-5771

2001

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.342

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.043)
Mit Volltextzugriff
(1.191)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Virology
(42)
Journal Of Hepatology
(38)
Bone
(28)
Jahrbuch Für Geschichte Lateinamerikas
(27)
Wiener Klinische Wochenschrift
(26)
Wiener Medizinische Wochenschrift
(26)
Hepatology
(25)
Plos Pathogens
(15)
The Journal Of Clinical Endocrinology And Metabolism
(13)
Plos One
(12)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

Anti‐infective properties of epigallocatechin‐3‐gallate (EGCG), a component of green tea

Virucidal activity of oral, hand, and surface disinfectants against respiratory syncytial virus

Characterization of Cell Lines Carrying Self-Replicating Hepatitis C Virus RNAs

CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells

Transcriptome analysis reveals a classical interferon signature induced by IFNλ4 in human primary cells

Transcriptome analysis reveals a classical interferon signature induced by IFN lambda 4 in human primary cells

Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway

838 TWO METHODS TO IDENTIFY CLINICAL HCV ISOLATES FOR IN VITRO STUDIES

Hepatitis C virus enters human peripheral neuroblastoma cells - evidence for extra-hepatic cells sustaining hepatitis C virus penetration

Long‐term follow‐up of successful hepatitis C virus therapy: waning immune responses and disappearance of liver disease are consistent with cure

Thermostability of seven hepatitis C virus genotypes in vitro and in vivo

1189 NEXT GENERATION SEQUENCING AND IN VITRO CHARACTERIZATION REVEAL POPULATION BOTTLENECKS AND FIXATION OF SELECTIVELY NEUTRAL MUTATIONS OCCURS POST-BI 201335 THERAPY

P233 THE NATURAL COMPOUND PENTA-O-GALLOYL-GLUCOSE, DERIVED FROM THE ROOT CORTEX MOUTAN, EFFICIENTLY INHIBITS HEPATITIS C-VIRUS ENTRY AND SHOWS EXCELLENT PHARMACOKINETIC PERFORMANCE IN VIVO

64 IDENTIFICATION AND CHARACTERIZATION OF A HEPATITIS C VIRUS CAPSID ASSEMBLY INHIBITOR

770 REGULATION OF HEPATITIS C VIRUS REPLICATION, VIRUS PRODUCTION AND INFECTIVITY BY BILE ACIDS

G09 : Targeting a host-cell entry factor barricades antiviral resistant HCV variants from on-therapy breakthrough in human-liver mice

The larger attachment glycoprotein of respiratory syncytial virus produced in primary human bronchial epithelial cultures reduces infectivity for cell lines

866 INACTIVATION OF HEPATITIS C VIRUS BY HUMAN MOTHER'S MILK

P763 ANALYSIS OF HCV MARKERS AND IMMUNE RESPONSES 5–20 YEARS AFTER SUCCESSFUL HCV THERAPY SUGGESTS THAT MOST PATIENTS ARE CURED

1238 CULTURE LONG-TERM TREATMENT WITH IMINOSUGARS-BASED HCV ASSEMBLY INHIBITORS DOES NOT LEAD TO VIRAL BREAKTHROUGH IN TISSUE CULTURE

P0674 : Clinically approved T-type calcium channel inhibitors prevent hepatitis C virus (HCV) membrane fusion in a genotype-dependent manner

877 OXIDIZED LOW DENSITY LIPOPROTEIN (OXLDL) IS A PAN-GENOTYPE INHIBITOR OF HCV ENTRY THAT ACTS IN A SR-BI DEPENDENT MANNER

872 IMPACT OF ANTI-RETROVIRAL AGENTS ON SUSCEPTIBILITY TO AND REPLICATION OF HEPATITIS C VIRUS IN VITRO

1162 TURMERIC CURCUMIN INHIBITS ENTRY OF ALL HEPATITIS C VIRUS GENOTYPES INTO HUMAN LIVER CELLS

A Particle-Associated Glycoprotein Signal Peptide Essential for Virus Maturation and Infectivity

Suchergebnisse filtern